April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Ahmed Kotb: Bispecific Antibodies vs. CAR-T for Relapsed/Refractory Follicular Lymphoma
Jan 30, 2025, 17:32

Ahmed Kotb: Bispecific Antibodies vs. CAR-T for Relapsed/Refractory Follicular Lymphoma

Ahmed Kotb, Hematologist and Bone marrow transplanter at King Faisal Specialist Hospital International Holding Company, shared a post on X:

Bispecific Antibodies vs. CAR-T for Relapsed/Refractory Follicular Lymphoma

BsAb

Off-the-shelf, outpatient, low toxicity

Possible indefinite treatment

CAR-T

Very high CR, long PFS, curative potential

Neurotoxicity risk,long wait time.

Ahmed Kotb: Bispecific Antibodies vs. CAR-T for Relapsed/Refractory Follicular Lymphoma